C12N 2760/16332
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/16332 (Use of virus as therapeutic agent, other than vaccine) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 3
- Assignees
- 3
- Inventors
- 7
- Latest grant
- 20 Mar 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Cryptic proteins expressed from defective viral genomes interfere with influenza virus replication11 Jul 2024US 2024/0228980 A1Wisconsin Alumni Research Foundation
- Directing Cancer Cells to Self-Destruct Through Vectoring Engineered Viruses6 Jun 2019US 2019/0169636 A1
- Genetically Engineered Equine Influenza Virus and Uses Thereof16 Oct 2008US 2008/0254060 A1Mount Sinai School of Medicine
Most cited
By later US patents